Overview Poster Sessions

The poster exhibition will be located in the main foyer of the CrossOver Research Building at Charité Campus Mitte.

Opening hours

Thursday, 6 September 2018 // 08:00-18:00
Friday, 7 September 2018 // 08:00-18:00
Saturday, 8 September 2018 // 08:00-16:00

Authors in Poster Session P- 01 to P- 06 will have the opportunity to present their poster(s) to interested congress participants on:

Thursday, 6 September 2018 // 11:00 – 11:30 (coffee break), 12:30 – 14:00 (lunch break), 16:00 – 16:30 (coffee break)
Friday, 7 September 2018 // 11:00 – 11:30 (coffee break)

Please put up your poster starting at 08:00 on Thursday, 6 September 2018, and take it down Friday, 7 September 2018, at 12:00. Posters that have not been removed by 12:15 will be disposed off.

Authors in Poster Session P- 07 to P-11 will have the opportunity to present their poster(s) to interested congress participants on:

Friday, 7 September 2018 // 12:30 – 14:00 (lunch break), 16:00 – 16:30 (coffee break)
Saturday, 8 September 2018 // 11:00 – 11:30 (coffee break), 12:30 – 14:00 (lunch break)

Please put up your poster starting at 12:30 on Friday, 7 September 2018, and take it down Saturday, 8 September 2018, at 16:00. Posters that have not been removed by 16:00 will be disposed off.

The Scientific Committee will award poster prizes sponsored by Sensorion for “Best Poster in Basic Research” and “Best Poster in Clinical Translational Research” with EUR 500 each.

P-01 // Aging

(1) H. Iwai, Osaka, Japan
Prevention of age-related hearing loss by transfer of CD4-positive T-cells deleting IL-1 receptor type 2-positive T-cells and regulatory T-cells

(2) Y. Honkura, Sendai, Japan
Evaluation of the role of NRF2 in the progression of age-related and noise-induced hearing losses

(3) J. Pang, Guangzhou, People's Republic of China
Modulation of autophagy by miR-34a/ATG9A/TFEB pathway in cochlear hair cell death and age-related hearing loss

P-02 // Clinical aspects of hearing and vestibular system

(1) A. Schilder, London, United Kingdom
Pharmacological treatments for hearing loss: From discovery to clinical application

(2) S.-H. Lee, Busan, Republic of Korea
Comparison of two different treatment protocols of systemic, intratympanic steroid and hyperbaric oxygen therapy in patients with severe to profound idiopathic sudden sensorineural hearing loss: A randomized controlled trial

(3) J.H. Seo, Jinju-Si, Republic of Korea
Osteoporosis and hearing loss in older Koreans: findings from the Korea National Health and Nutrition Examination Survey (KNHANES) 2009-2011

(4) J.H. Seo, Jinju-Si, Republic of Korea
Reverse bithermal caloric test

(5) H.J. Lee, Incheon, Republic of Korea
Bony cochlear nerve canal stenosis in pediatric unilateral sensory neural hearing loss

(6) H. Schmitt, Hannover, Germany
Disease-specific analysis of human perilymph by mass spectrometry

P-03 // Inner ear development

(1) B. Lee, Daegu, Republic of Korea
Exocyst complex member Exoc5 is required for survival of hair cells and spiral ganglion neurons and maintenance of hearing

(2) F. Ceriani, Sheffield, United Kingdom
Spontaneous and coordinated calcium activity of cochlear sensory and non-sensory cells drives the maturation of outer hair cell afferent innervation

P-04 // Ototoxicity and protection

(1) Y.-R. Kim, Dae-Gu, Republic of Korea
Protective and alleviative effects of alpha-lipoic acid on ototoxicity caused by Cisplatin

(2) J. Ogier, Parkville, Australia
Inhibition of Apoptotic Signal Regulating Kinase 1 (ASK1). A potential strategy for the prevention of acquired hearing loss

(3) H. Vink, Utrecht, The Netherlands
Combined BDNF and NT-3 treatment of the auditory nerve in deafened guinea pigs

(4) Y.-H. Choung, Suwon, Republic of Korea
Statin use for hearing preservation in diabetic mice

(5) J.M. Bermudez Muñoz, Madrid, Spain
G6PD overexpression protects from oxidative stress and ameliorates ARHL progression

(6) J. Schwieger, Hannover, Germany
Alginate as carrier for BDNF-producing MSCs: protection and neurite guidance of auditory neurons in vitro

(7) J. Schulze, Hannover, Germany
C3 exoenzyme enhanced the survival of spiral ganglion neurons by Rho GTPase and p38

(8) A.-R. Lyu, Daejeon, Republic of Korea
Effect of dexamethasone on the expression of cochlear glucocorticoid receptor and serum corticosterone level in noise induced hearing loss: A comparison of administration time

(9) S. Shin, Daejeon, Republic of Korea
Effects of dexamethasone on intracochlear inflammation and residual hearing after cochleostomy: A comparison of administration routes

(10) J. Dyhrfjeld-Johnsen, Montpellier, France
Comparative characterization of cisplatin-induced ototoxic lesion in vestibular and cochlear neuron primary cultures using multiwell, live-cell imaging

(11) J. Dyhrfjeld-Johnsen, Montpellier, France
Live cell imaging of gentamicin induced ototoxicity in organ of corti explant cultures as a High Content Screening assay

(12) M. Sekulic, Basel, Switzerland
Aminoglycoside-induced auditory hair cell loss ameliorated by a combined approach of NFAT inhibition and antioxidative protection

(13) D.-K. Kim, Daejeon, Republic of Korea
Optimized phospholipid-based nanoparticles for inner ear drug delivery and therapy

(14) C.H. Jang, Gwangju, Republic of Korea
Matrix removal of labyrinthine fistulae by non-suction technique withintraoperative dexamethasone injection

(15) H. Lin, Guangzhou, People's Republic of China
Mitochondrial fission contributes to oxidative stress-induced mitophagy in HEI-OC1 cells

(16) H. Lin, Guangzhou, People's Republic of China
SIRT1 activates PGC1-mediated mitochondrial biogenesis pathway to protect HEI-OC1 auditory cells against cisplatin induced mitochondrial function and ototoxicity

(17) M. Park, Seoul, Republic of Korea
Biocompatibility and therapeutic effect of three different intra-tympanic drug-delivery vehicles in acute acoustic trauma

(18) L. Astolfi, Padua, Italy
Cisplatin ototoxicity and nephrotoxicity in an in vivo rat model: experimental protocols

(19) G. Nacher-Soler, Geneve, Switzerland
Novel 3R mouse model to study cisplatin ototoxicity without systemic effects

(20) F. Rousset, Geneva, Switzerland
Biopolymer-based formulations for intratympanic dexamethasone delivery to the inner ear

(21) M. Bassiouni, Berlin, Germany
Expression of the microglial marker TMEM119 in the postnatal mouse cochlea

(22) A.R. Fetoni, Rome, Italy
Cisplatin-induced ototoxicity can be counteracted by polyphenols

P-05 // Stem cell

(1) A.-R. Ji, Sheffield, United Kingdom
Differentiation of human embryonic stem cells into otic epithelial progenitor cells and their maturation in 2D and 3D culture systems

(2) F. Moeinvaziri, Tehran, Iran
Generation of inner ear organoid-like structures from human induced pluripotent stem cells

(3) M. Hosoya, Tokyo, Japan
Low-dose rapamycin therapy proposed by an in vitro chronic disorder model of Pendred Syndrome using disease specific iPS cells

(4) I. Fukunaga, Tokyo, Japan
Generation of Stem Cell derived inner ear Connexin 26 gap junction plaque forming cells

P-06 // Vestibular system

(1) P. Spaiardi, Pavia, Italy
Exocytosis at mammalian vestibular ribbon synapses shows a high-order Ca2+ dependence and does not require synaptotagmin-4

(2) J. Dyhrfjeld-Johnsen, Montpellier, France
Electrophysiological functional assessment of vestibular and cochlear primary neuron cultures using microelectrode array recordings

(3) M.-B. Kim, Incheon, Republic of Korea
Vestibular function change in vasopressin-induced hydrops model

(4) H.-J. Kim, Incheon, Republic of Korea
Effects of hypergravity on gene expression of serotonin receptors of vestibular nuclei in rats

(5) S. Park, Seoul, Republic of Korea
MicroRNA Expression in the Vestibular Nucleus after Unilateral Labyrinthectomy

P-07 // Cochlear implantation (CI)

(1) S.-J. Oh, Busan, Republic of Korea
Audiologic, surgical and subjective outcomes of active transcutaneous bone conduction implant

(2) M. Müller, Planegg-Martinsried, Germany
Comparison of single cell spike timing in the brainstem in response to Cochlear Implant and acoustic stimulation

(3) V. Radotiæ, Split, Croatia
Characterization of spiral ganglion neurons in vitro cultured on 3D complementary metal-oxide-semiconductor chips

(4) V. Scheper, Hannover, Germany
The effect of antioxidants and magnesium on residual hearing preservation in cochlea-implant-patients

(5) M. Peter, Hannover, Germany
High-resolution microscopy for determining an early response to electrical stimulation

(6) J.-H. Jeong, Goyang, Republic of Korea
Limited high pitch perception of auditory brainstem implantation

(7) L. Rahbar Nikoukar, Hannover, Germany
Summating potential as a marker of intracochlear position of electrodes

(8) C.H. Jang, Gwangju, Republic of Korea
Biodegradable piperacillin-tazobactam-eluting nanofibrous mat against ciprofloxacin-resistant Pseudomonas aeruginosa (CRPA) biofilm formation of cochlear implant

(9) C.H. Jang, Gwangju, Republic of Korea
Efficacy of non-skin penetrating transcutaneous implantable bone anchored hearing device (cochlear BAHA attract)

(10) M. Okada, Toon, Japan
The natural progression of low-frequency hearing level in patients with high-frequency hearing loss

(11) D.H. Kim, Seoul, Republic of Korea
Prediction of the auditory ganglion cell population from the electrically evoked auditory potential via multi-site promontory stimulation

(12) K. Doi, Osaka, Japan
3D-CT analysis of FMT angle to RW/OW after VSB surgery

(13) S.-Y. Lee, Seoul, Republic of Korea
Prognosis prediction of cochlear implantation using evoked auditory brainstem response

(14) M. Müller, Tübingen, Germany
Comparison of electrically evoked auditory brainstem response and compound action potential

(15) M. Candito, Padua, Italy
Biocompatibility of lithium niobate and barium titanate nanoparticles in an inner ear cell line

(16) M. Müller, Tübingen, Germany
Cochlear implant performance and genetic diagnostics

P-08 // Genetics

(1) M.-A. Kim, Daegu, Republic of Korea
Polyethylenimine-mediated targeted gene therapy using CRISPR/Cas9

(2) T. Miwa, Yatsushiro, Japan
Deficiency of mitochondrial tRNA modification causes progressive hearing loss through metabolic senescence in the inner ear

P-09 // Hearing and cognition

(1) J. Han, Seoul, Republic of Korea
Cognitive decline and increased hippocampal p-tau expression in mice with hearing loss

(2) M. Shukla, Delhi, India
Adenosine A2A receptor agonist mitigates deleterious effects of NIHL on neuroprotection and spatial reference memory in rats

(3) P. Marchetta, Tübingen, Germany
Central stress receptors influence differentially sound-induced long-term changes in auditory nerve response and central auditory processing

(4) A.R. Fetoni, Rome, Italy
Noise-induced hearing loss as a risk factor AD cognitive decline

P-10 // Hearing function

(1) N. Harada, Osaka, Japan
Extracellular ATP-induced hydrogen sulfide production in outer hair cells

(2) L. Rimskaya-Korsakova, Moscow, Russia
Contribution of multiple response of peripheral fibres in intensity discrimination and loudness formation of short high-frequency sounds

(3) T. Nishiyama, Tokyo, Japan
Deficiency of Lats1 a configuration kinase of Hippo pathway causes congenital hearing loss in mice

(4) B.-G. Kim, Bucheon, Republic of Korea
Effect of sleep deprivation on hearing levels in rats

(5) M. Luque Calvo, Innsbruck, Austria
Hyperpolarization-activated and cyclic nucleotide-gated channels in the mammalian inner ear

(6) Y. Nonomura, Niigata, Japan
N-glycan profiles of the epithelial-like tissue in the mammalian cochlea

(7) S.H. Kim, Seoul, Republic of Korea
Identification of evidence for autoimmune pathology of bilateral sudden sensorineural hearing loss using proteomic analysis

(8) K. Mizutari, Saitama, Japan
Cochlear histopathology after shock wave exposure

(9) P. Perin, Pavia, Italy
Segmentation and cell feature extraction in the clarified auditory system

(10) A.L. Nuttall, Portland, OR, USA
The organ of Corti processes complex auditory signals to extract the envelope of the complex

P-11 // Tinnitus

(1) Y.-H. Kim, Seoul, Republic of Korea
Correlation of cognitive and tinnitus characteristics in aged patients with chronic tinnitus

(2) H.-J. Jeong, Busan, Republic of Korea
The effect of selective serotonin reuptake inhibitor in the treatment of chronic tinnitus

(3) T. Ohbuchi, Kitakyushu, Japan
The relationship between subjective pitch matched tinnitus loudness and tinnitus handicap inventory in patients with chronic tinnitus

(4) C. Ducène, Bruxelles, Belgium
Comparison of two tinnitus acoustic therapies using either lateral inhibition or awareness decrease (TRT)

(5) D. Korth, Jena, Germany
Can patients determine their tinnitus frequency using recursive matching?

(6) K. Tziridis, Erlangen, Germany
The development of a tinnitus percept after noise trauma is associated with synaptopathy of inner hair cells in Mongolian gerbils

(7) J.-H. Lim, Seoul, Republic of Korea
Assessment of tinnitus in mouse models using gap prepulse inhibition of acoustic startle

(8) A. Elarbed, Nottingham, United Kingdom
Tinnitus and stress in adults: A scoping review